Need professional-grade analysis? Visit stockanalysis.com
$79.25M
N/A
N/A
N/A
Pliant Therapeutics Inc (PLRX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.28, down 0.78% from the previous close.
Over the past year, PLRX has traded between a low of $1.09 and a high of $1.87. The stock has lost 12.9% over this period. It is currently 31.6% below its 52-week high.
Pliant Therapeutics Inc has a market capitalization of $79.25M.
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.